Journal of AdvancedMedical and Dental Sciences Research

Background: When compared to bare metal stents (BMS), the first generation drug eluting stents (DES) covered with a permanent polymer had lower restenosis rates. The present study compared strut BP-coated sirolimus-eluting stent (BP-SES) versus the durable coating everolimus-eluting stent (DP-EES) in patients with myocardial infarction. Materials & Methods: 70 cases of myocardial infarction of both genders were divided into 2 groups of 35 each. Group I patients received thin strut biodegradable polymer-coated sirolimus-eluting stent (BP-SES) and in group II patients received durable coating everolimus-eluting stent (DP-EES). Results: Out of 70 patients, males were 40 and females were 30. The mean stents used per patients was 1.56 in group I and 1.54 in group II, post- dilatation was seen in 22.5% in group I and 27.8% in group II, thrombectomy was observed in 12% in group I and 10.4% in group II, maximum implantation pressure was 14.8 in group I and 14.2 in group II, direct stent implantation was seen in 40% in group I and 48% in group II. The difference was significant (P< 0.05). Mortality was observed 5 in group I and 8 in group II. The difference was significant (P< 0.05). Conclusion: Authors found both strut BP-coated sirolimus-eluting stent (BP-SES) and the durable coating everolimus-eluting stent (DP-EES) were equally effective in patients with myocardial infarction.